English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52777275    線上人數 :  618
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 223106-223130 / 2348719 (共93949頁)
<< < 8920 8921 8922 8923 8924 8925 8926 8927 8928 8929 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立臺灣大學 2008-06 Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Yang, CM; Yeh, PT; Yang, CH; Chen, MS.
國立臺灣大學 2009 Bevacizumab Pretreatment in Vitrectomy with Silicone Oil for Severe Diabetic Retinopathy 葉伯廷; 楊中美; 林友祺; 陳慕師; 楊長豪; YEH, PO-TING; YANG, CHUNG-MAY; LIN, YU-CHI; CHEN, MUH-SHY; YANG, CHANG-HAO
臺大學術典藏 2022-07-14T07:25:57Z Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy Yeh P.-T.; Yang C.-M.; Lin Y.-C.; Chen M.-S.; CHANG-HAO YANG
臺大學術典藏 2022-07-15T06:43:28Z Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy Yeh P.-T.; CHUNG-MAY YANG; Lin Y.-C.; Chen M.-S.; Yang C.-H.
臺大學術典藏 2022-07-20T06:34:01Z Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy PO-TING YEH; Yang C.-M.; Lin Y.-C.; Chen M.-S.; Yang C.-H.
臺北醫學大學 2018-07 Bevacizumab Reduces S100A9+ MDSC Linked to Intracranial Control in Patients with EGFR Mutant Lung Adenocarcinoma. 馮博皓; Po-Hao Feng, Kuan-Yuan Chen, Yu-Chen Huang, Ching-Shan Luo, Shen Ming Wu, Tzu-Tao Chen, Chun-Nin Lee, Chi-Tai Yeh, Hsiao-Chi Chuang, Chia-Li Han, Chiou-Feng Lin, Wei-Hwa Lee, Chih-Hsi Kuo, Kang-Yun Lee
臺大學術典藏 2013 Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU; Cheng A.-L.
國立成功大學 2013 Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii
國立臺灣大學 2013 Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 許駿; 孫家棟
臺大學術典藏 2020-04-10T12:16:09Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.; Cheng A.-L.; Jin K.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; YU-YUN SHAO; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.
臺大學術典藏 2020-04-10T12:51:11Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.; Kang Y.K.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Chiun Hsu; Cheng A.-L.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.
臺大學術典藏 2021-03-18T02:02:48Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.;Kang Y.K.;Yang T.-S.;Chia-Tung Shun;Shao Y.-Y.;Su W.-C.;Sandoval-Tan J.;Chiou T.-J.;Jin K.;Hsu C.;Cheng A.-L.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-09-01T01:53:47Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; ANN-LII CHENG
高雄醫學大學 2009 Bevacizumab在缺血性視神經病變治療的應用 -- 初報  吳文權;賴昱宏 
國立臺灣大學 2010 Bevacizumab結膜下腔注射在眼輪部幹細胞缺損模式中對於角膜新生血管與角膜結膜化的抑制效果 郭廣慈; Kuo, Kuang-Tzu
國立臺灣科技大學 2017 Bevel gear cutting using a disk tool on a CNC five-axis machine Shih, Y.-P.;Sun, Z.-H.;Sheen, B.-T.
亞洲大學 2007 Beverage in Catering and Customers? Satisfaction Degree an Example f Customers for Catering in Central Taiwan Area chen mei ling
嘉南藥理大學 2009 Beverage Industry EBSCO-HTC
淡江大學 2017年10月14日 Beverage preparation system with a tangible user interface for vocational school training Ku, David Tawei;Ho, Sasha
嘉南藥理大學 2009 Beverage World EBSCO-HTC
淡江大學 2011-08 Beveridge 曲線之再探討:空間共整合模型之應用 林俊宏
國立政治大學 2013 Beveridge-Nelson分解趨勢方法對匯率預測模型績效之影響 -以新台幣兌美元匯率為例 紀筌惟; Chi, Chuan Wei
國立成功大學 2025-07-21 BEvST: 透過超標記注意力實現高效的多視角感知鳥瞰圖分割方法 周韋良; Chou, Wei-Liang
臺大學術典藏 2021-08-31T06:42:24Z Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse Kuo S.-H.; Tsai H.-J.; Weng W.-H.; Li C.-C.; Yeh K.-H.; Chen L.-T.; ANN-LII CHENG
臺大學術典藏 2021-01-28T01:06:33Z Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse Kuo S.-H.;Tsai H.-J.;Weng W.-H.;Li C.-C.;Kun-Huei Yeh;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Tsai H.-J.; Weng W.-H.; Li C.-C.; KUN-HUEI YEH; Chen L.-T.; Cheng A.-L.

顯示項目 223106-223130 / 2348719 (共93949頁)
<< < 8920 8921 8922 8923 8924 8925 8926 8927 8928 8929 > >>
每頁顯示[10|25|50]項目